RxDoctor Payments DataLook up a doctor →

Michael Schwartz, MD

Orthopaedic Surgery · Plano, TXNPI 1427041557

Payments from drug & device makers

$993,336in general payments, 2019–2025

Across 131 payments — averaging $7582.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$593K
  • Lazurite Inc.$182K
  • Zurimed Technologies Inc.$127K
  • Medical Device Business Services, Inc.$49K
  • Trice Medical, Inc.$13K
  • Depuy Synthes Products, Inc.$12K
  • plus $18K from 18 others
$101,380in research payments, 2019–2025

Across 20 payments — averaging $5069.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$101K

What the payments were for

  • Royalty or licence$435,43168%
  • Consulting fees$35,4436%
  • Speaking & faculty fees$2000%
  • Travel & lodging$4,1421%
  • Food & beverage$5,5051%
  • Entertainment$2160%
  • Other$157,91025%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$993,336 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$239,709
Medicare patients
349
Services billed
4,055

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib45$907
Diclofenac Sodium13$775
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen89$735
Cephalexin16$319
Meloxicam102$260
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen13$92
Amoxicillin23$47
Tramadol Hcl17$32

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Plano

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →